Item 8.01 Other Events.
On April 6, 2020, Global Wholehealth Partners Corporation (the "Company")
received an Acknowledgment Letter (the "Letter") from the U.S. Food and Drug
Administration (the "FDA") that the Center for Devices and Radiological Health
of the FDA has received the Company's Rapid Diagnostic IgG/IgM 10 minute Rapid
test application submitted by Charles Strongo, the Company's Chief Executive
Officer. The Rapid Diagnostic IgG/IgM 10 minute Rapid test requires no machine.
The Company's submission has been assigned the unique document control number
EUA200181.
A copy of the Letter is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Document Location
99.1 FDA Letter received April 6, 2020. Filed Herewith
2
© Edgar Online, source Glimpses